NCT00001353View on ClinicalTrials.gov

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 1993

Study Completion Date

March 31, 2002

Conditions
Acquired Immunodeficiency SyndromeHIV Infection
Interventions
DRUG

Genetically Marked Syngeneic T Lymphocytes

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH